Investigators concluded, “There is an urgent need to implement well-designed studies to evaluate the effectiveness and safety of medical marijuana for treating adults with migraines.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“These data are consistent with other surveys showing that marijuana regulation policies can be implemented in a manner that provides access for adults while simultaneously limiting youth access and misuse.”
Investigators concluded, “Medical cannabis treatment … demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects.”
Researchers reported, “Topical CBD treatment demonstrated significant improvements in … arthritis-related pain and disability without adverse events.”
Current cannabis use was “consistently associated with smaller waist circumference, lower BMI, and lower risks of … obesity in patients with chronic HCV infection.”
Authors theorized that more frequent consumers were more tolerant to the effects of cannabis and also engaged in more compensatory driving behaviors.
“Extending our results to other states, we find that medical cannabis legalization has reduced auto insurance premiums by $1.5 billion in all states that have currently legalized,” authors concluded.
Investigators concluded: “[M]ost cancer comorbid symptoms improved significantly during six months of medical cannabis treatment.”